Ginkgo Bioworks Holdings DNA
NYSE DNA
$12.44 +0.48 (+4.01%)
As of: Sep 30, 2026 · 10:25 AM EDT

Ginkgo Bioworks Holdings (DNA) EBIT Margin (2020 - 2026)

Updated

Ginkgo Bioworks Holdings (DNA) posted EBIT Margin of -290.47% for Q2 2026, down 141.85 percentage points from -148.63% a year earlier but up 76.03 percentage points from the prior quarter.

Analysis

Ginkgo Bioworks Holdings (DNA) EBIT Margin (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT Margin at Ginkgo Bioworks Holdings was -259.86%, down 118.16 percentage points year-over-year; for FY2025, it came in at -185.29%, up 61.25 percentage points from FY2024.

  • Annual EBIT Margin has increased for four consecutive years, though with a five-year change of -6.54 percentage points (FY2020 to FY2025).
  • In prior years, Ginkgo Bioworks Holdings' EBIT Margin was -246.54% in FY2024 (+97.22 pp), -343.76% in FY2023 (+118.65 pp), -462.41% in FY2022 (+120.21 pp) and -582.62% in FY2021 (-403.86 pp).
  • Quarterly EBIT Margin has run from a low of -1134.55% in Q4 2021 to a high of -34.37% in Q3 2021 over five years.
  • On a year-over-year basis, EBIT Margin increased in five of the last eight quarters, with an average year-over-year change of +99.29 percentage points.
  • The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2022, with a gain of 899.66 percentage points; the weakest was Q4 2021, with a drop of 960.21 percentage points.
  • According to Business Quant data, EBIT Margin for the three prior quarters was -366.51% (Q1 2026), -211.86% (Q4 2025) and -231.78% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Iqvia Holdings 44.55 Bn 36.39 Bn 1.44 Bn 11.58%
2 Medpace Holdings 17.19 Bn 15.25 Bn 201.64 Mn 20.76%
3 Charles River Laboratories International 14.06 Bn 13.30 Bn 363.37 Mn 11.94%
4 Icon 13.44 Bn 10.55 Bn 479.29 Mn 6.68%
5 Fortrea Holdings 1.91 Bn 1.29 Bn 139.20 Mn 2.18%
6 Ginkgo Bioworks Holdings 665.78 Mn -96.30 Mn 18.44 Mn -290.47%
7 Evotec SE 565.34 Mn -1.01 Bn - -
8 Champions Oncology 68.06 Mn 43.71 Mn 7.70 Mn -2.69%
9 MindWalk Holdings 62.59 Mn 26.81 Mn 1.61 Mn -159.86%
10 Natural Alternatives International 10.67 Mn -22.35 Mn 383,000.00 -11.31%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -290.47%
Mar 31, 2026 -366.51%
Dec 31, 2025 -211.86%
Sep 30, 2025 -231.78%
Jun 30, 2025 -148.63%
Mar 31, 2025 -211.80%
Dec 31, 2024 -236.29%
Sep 30, 2024 -61.99%
Jun 30, 2024 -396.66%
Mar 31, 2024 -469.12%
Dec 31, 2023 -512.49%
Sep 30, 2023 -516.68%
Jun 30, 2023 -228.57%
Mar 31, 2023 -267.34%
Dec 31, 2022 -234.89%
Sep 30, 2022 -986.38%
Jun 30, 2022 -447.92%
Mar 31, 2022 -401.04%
Dec 31, 2021 -1,134.55%
Sep 30, 2021 -34.37%
API Access

Ginkgo Bioworks Holdings EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=DNA&period=max&api_key=YOUR_API_KEY